Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 CoreRx | Contract Pharma

What are you searching for?

Sign in

Search by

CoreRx

Company Headquarters

14205 Myerlake Circle , Clearwater, FL, 33760, US

Driving Directions Phone: View Phone Fax: View Fax
View website

Request more information from CoreRx

Request more information from CoreRx

Categories from CoreRx

Analytical Methods Development
Contract Development and Manufacturing Organization (CDMO)
Contract Manufacturing
Dosage Form Development
Drug Development Services
Encapsulation
Fluid Bed Processing
Formulation Development
Formulation Services
Formulation, Controlled Release
Granulation
HPLC
Manufacturing, Capsules
Manufacturing, Controlled Substances
Manufacturing, Creams & Ointments
Manufacturing, Dose Form, Non-Sterile
Manufacturing, Liquids
Manufacturing, Oral Drug Delivery
Manufacturing, Orally Dispersible Tablet
Manufacturing, Powders, Non-Sterile
Manufacturing, Semisolids
Manufacturing, Solid Dosage
Manufacturing, Solutions & Suspensions
Manufacturing, Suppositories
Manufacturing, Sustained Release
Manufacturing, Syringes, Pre-filled
Manufacturing, Tablets
Manufacturing, Topicals
Methods Development
Microdosing
Packaging, Blister
Packaging, Capsules
Packaging, Clinical Trials
Packaging, Liquids
Packaging, Powders
Packaging, Services, Other
Packaging, Solid Dosage
Particle Size Analysis
Preclinical Testing
Preformulation
Quality Control Testing
R&D Services
Scale-Up
Stability Studies
Stability, ICH
Syringe Filling
Tablet Coating
UV-VIS Spectrophotometer Analysis
Validation, Clinical
Validation, Manufacturing
Screening Permeability as a Tool in Formulation Selection

White Papers / Tech Papers

Screening Permeability as a Tool in Formulation Selection

Improving bioavailability can be crucial to creating a dosage form that is easy to use and meets requirements for patient compliance.

Released By CoreRx

Related Content

Promotions & Moves

Owen Murray Tapped as CEO of Combined Bend Bioscience, CoreRx and Societal Entities

Murray brings extensive expertise spanning early product development through commercialization.

VideoBites

Contract Pharma Talks with Scott Rizzo on CoreRx’s Acquisition of Societal

Co-President of Operations for Societal CDMO talks about the capabilities of the combined CoreRx and Societal CDMO businesses.

Breaking News

CoreRx Completes Acquisition of Societal CDMO

Societal CDMO is now a wholly-owned subsidiary of CoreRx.

Breaking News

CoreRx to Acquire Societal CDMO in $130M Deal

Will create an enhanced CDMO with broad capabilities spanning early-stage formulation development through commercial manufacturing and packaging.

Breaking News

NovaQuest Invests in Bend Bioscience to Broaden CoreRx Offering

Bend Bioscience to focus on new innovation, product development, and manufacturing.

Promotions & Moves

CoreRx Appoints Dan Dobry as Chief Strategy Officer

Brings 25 years of experience as a global CDMO business leader and drug delivery innovator.

Breaking News

CoreRx Expands Capabilities

Invests in new drug development and manufacturing technologies.

Breaking News

CoreRx Appoints Sitakant Chaudhury as Chief Financial Officer

Chaudhury brings to CoreRx over 25 years of experience building, scaling, transforming and leading world-class organizations.

Promotions & Moves

CoreRx Expands Product Development Team

Adds Amber Broadbent, Ph.D. and Scott Bone, M.S. to its team.

Features

CEO Spotlight: Todd R. Daviau, CoreRx

Following the recent investment from NovaQuest, CoreRx plans for the future.

By: Kristin Brooks

Online Exclusives

Solid Dose Market Trends

A Q&A with Mark DaFonseca, chief business officer at CoreRx.

Breaking News

NovaQuest Private Equity Acquires CoreRx

New strategic financial sponsor to support continued growth and capability expansion.

Breaking News

CoreRx Fully Operational in New Product Development Center

Expansion gives CoreRx’s clients access to over 150,000 sq. ft. of space at the ICOT center campus.

Collaborations & Alliances

JanOne Strikes Clinical Deal with CoreRx

CoreRx to provide formulation and manufacturing of TV1001SR, a treatment for Peripheral Artery Disease

Breaking News

CoreRx Installs Optel Serialization and Aggregation System

To support commercial liquid dosage form manufacturing